Elutia Inc. (ELUT) stock
ELUTNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 9/3011% below fair value
$0.85+0.03 (+3.77%)
Close on Nov 17, 2026Market cap $37.82MP/E –Yield –
Elutia cash
Cash and short-term investments held at the end of each period.
Elutia's cash was $19.90M at Jun 30, 2026. For fiscal 2025 it was $36.35M, up 174.6% from the year before. The highest annual figure on record is $39.53M in fiscal 2020.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $36.35M | +174.6% |
| FY2024 | Dec 31, 2024 | $13.24M | -31.3% |
| FY2023 | Dec 31, 2023 | $19.28M | +13.5% |
| FY2022 | Dec 31, 2022 | $16.99M | -44.2% |
| FY2021 | Dec 31, 2021 | $30.43M | -23.0% |
| FY2020 | Dec 31, 2020 | $39.53M | +1426.3% |
| FY2019 | Dec 31, 2019 | $2.59M | +7.3% |
| FY2018 | Dec 31, 2018 | $2.41M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $19.90M | +134.1% |
| Q1 FY2026 | Mar 31, 2026 | $28.49M | +64.1% |
| Q4 FY2025 | Dec 31, 2025 | $36.35M | +174.6% |
| Q3 FY2025 | Sep 30, 2025 | $4.72M | -81.7% |
| Q2 FY2025 | Jun 30, 2025 | $8.50M | -53.3% |
| Q1 FY2025 | Mar 31, 2025 | $17.36M | +38.3% |
| Q4 FY2024 | Dec 31, 2024 | $13.24M | -31.3% |
| Q3 FY2024 | Sep 30, 2024 | $25.74M | +77.3% |
| Q2 FY2024 | Jun 30, 2024 | $18.19M | +95.7% |
| Q1 FY2024 | Mar 31, 2024 | $12.55M | +6.5% |
| Q4 FY2023 | Dec 31, 2023 | $19.28M | +13.5% |
| Q3 FY2023 | Sep 30, 2023 | $14.52M | -12.1% |
| Q2 FY2023 | Jun 30, 2023 | $9.30M | -58.1% |
| Q1 FY2023 | Mar 31, 2023 | $11.79M | -61.3% |
| Q4 FY2022 | Dec 31, 2022 | $16.99M | -24.6% |
| Q2 FY2022 | Jun 30, 2022 | $16.51M | -41.7% |
| Q1 FY2022 | Mar 31, 2022 | $22.18M | -27.1% |
| Q4 FY2021 | Dec 31, 2021 | $30.43M | -23.0% |
| Q3 FY2021 | Sep 30, 2021 | $22.54M | +1360.0% |
| Q2 FY2021 | Jun 30, 2021 | $28.30M | +2758.8% |
| Q1 FY2021 | Mar 31, 2021 | $30.41M | +5510.7% |
| Q4 FY2020 | Dec 31, 2020 | $39.53M | +1426.3% |
| Q3 FY2020 | Sep 30, 2020 | $1.54M | +465.6% |
| Q2 FY2020 | Jun 30, 2020 | $990.00K | -59.0% |
| Q1 FY2020 | Mar 31, 2020 | $542.00K | – |
| Q4 FY2019 | Dec 31, 2019 | $2.59M | – |
| Q3 FY2019 | Sep 30, 2019 | $273.00K | – |
| Q4 FY2018 | Dec 31, 2018 | $2.41M | – |
See a number that looks wrong?